Management of Alcohol Withdrawal Syndrome with Chlordiazepoxide

Primary Indications

• The American Association for the Study of Liver Diseases recommends chlordiazepoxide as a "gold standard" treatment for Alcohol Withdrawal Syndrome (AWS) due to its efficacy in reducing withdrawal symptoms and preventing seizures and delirium tremens 1, 2

Alcohol Withdrawal Management

Mechanism and Benefits

• Chlordiazepoxide is a long-acting benzodiazepine that works through activation of gamma-aminobutyric acid (GABA) receptors, providing anxiety relief, sedation, and somnolence 2
• Chlordiazepoxide is particularly effective in preventing withdrawal seizures and delirium tremens in patients with alcohol dependence 1
• Typical dosing for AWS is 25-100 mg orally every 4-6 hours, with dose titration based on symptom severity 2

Clinical Considerations

• For patients with severe liver disease, the European Association for the Study of the Liver suggests that shorter-acting benzodiazepines like lorazepam may be safer alternatives 1